FEATURED COMPANIES
- AstraZeneca
- Bavarian Nordic
- Bayer AG
- Bio Farma
- GlaxoSmithKline plc
- Merck & Co., Inc.
Respiratory Disease Vaccine Market: Introduction
Respiratory disease affects the lungs and other parts of the respiratory system. In addition to tobacco smoke, other risk factors include air pollution, occupational chemicals and dust, and frequent lower respiratory infections during childhood.
Chronic respiratory diseases (CRDs) are diseases of the airways and other structures of the lung. Some of the most common is chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases, and pulmonary hypertension.
Treatments for each chronic respiratory disease vary and the ideal solution is the reduction and avoidance of risk factors. Neither asthma nor chronic obstructive pulmonary disease (COPD) can be cured but treatments can reduce symptoms, prevent escalation, and improve quality of life.
Population protection by vaccination against infections has been one of the major achievements of public health and is of considerable importance in controlling respiratory diseases.
Market Dynamics
The market is driven by factors such as the increasing prevalence of respiratory diseases, a growing number of vaccines under trial, etc. While the lack of inadequate delivery infrastructure and limited consumer awareness are some of the restraining factors. Increasing R&D expenditure and the increasing availability of vaccines through various collaborations is creating opportunities for market growth.
Segments Covered
The Global Respiratory Disease Vaccine Market is segmented on the basis of infection, type, and age group.
Global Respiratory Disease Vaccine Market, By Infection
Introduction
Influenza Virus
Pertussis
Streptococcus Pneumoniae
Tuberculosis
Global Respiratory Disease Vaccine Market, By Type
Bacterial Vaccine
Combination Vaccine
Viral Vaccine
Global Respiratory Disease Vaccine Market, By Age Group
Adolescent Vaccination
Adult Vaccination
Infant Vaccination
Why buy this report?
The report offers a comprehensive evaluation of the global respiratory disease vaccine market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes in-depth market analysis using Porter’s 5 force model. The impact of Covid-19 on the market is also featured in the report.
Report Highlights:
A complete analysis of the market including parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
FEATURED COMPANIES
- AstraZeneca
- Bavarian Nordic
- Bayer AG
- Bio Farma
- GlaxoSmithKline plc
- Merck & Co., Inc.
1 Introduction
1.1 Objectives of the study
1.2 Market Definition
1.3 Currency
1.4 Years Considered for the study
1.5 Language
1.6 Key Benefits for Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Assessment
2.3.1 Market Size Estimation
2.3.2 Market Share Analysis
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Global Respiratory Disease Vaccine Market Size, by Geography
5 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Trends
6 Market Analysis
6.1 Porter’s Five Forces Analysis
6.2 Impact of COVID-19
7 Global Respiratory Disease Vaccine Market, By Infection
7.1 Introduction
7.2 Influenza Virus
7.3 Pertussis
7.4 Streptococcus Pneumoniae
7.5 Tuberculosis
8 Global Respiratory Disease Vaccine Market, By Type
8.1 Bacterial Vaccine
8.2 Combination Vaccine
8.3 Viral Vaccine
9 Global Respiratory Disease Vaccine Market, By Age Group
9.1 Adolescent Vaccination
9.2 Adult Vaccination
9.3 Infant Vaccination
10 Americas Respiratory Disease Vaccine Market
10.1 Argentina
10.2 Brazil
10.3 Canada
10.4 Mexico
10.5 United States
11 Europe, Middle East & Africa Respiratory Disease Vaccine Market
11.1 France
11.2 Germany
11.3 Italy
11.4 Netherlands
11.5 Qatar
11.6 Russia
11.7 Saudi Arabia
11.8 South Africa
11.9 Spain
11.10 United Arab Emirates
11.11 United Kingdom
12 Asia-Pacific Respiratory Disease Vaccine Market
12.1 Australia
12.2 China
12.3 India
12.4 Indonesia
12.5 Japan
12.6 Malaysia
12.7 Philippines
12.8 South Korea
12.9 Thailand
13 Competitive Scenario
13.1 Merger & Acquisition
13.2 Agreement, Collaboration, & Partnership
13.3 New Product Launch & Enhancement
13.4 Investment & Funding
13.5 Award, Recognition, & Expansion
14 Company Profiles
14.1 AstraZeneca
14.2 Bavarian Nordic
14.3 Bayer AG
14.4 Bio Farma
14.5 Dynavax Technologies Corporation
14.6 Emergent BioSolutions, Inc.
14.7 GlaxoSmithKline plc
14.8 Merck & Co., Inc.
14.9 Pfizer Inc.
14.10 Sanofi S.A.
14.11 Seqirus USA Inc.
15 Appendix
15.1 Questionnaire
List of Tables
Table 1 Global Respiratory Disease Vaccine Market Size, 2017-2025 (USD Million)
Table 2 Global Respiratory Disease Vaccine Market Size, By Geography, 2017-2025 (USD Million)
Table 3 Global Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 4 Global Respiratory Disease Vaccine Market Size, By Influenza Virus, By Geography, 2017-2025 (USD Million)
Table 5 Global Respiratory Disease Vaccine Market Size, By Pertussis, By Geography, 2017-2025 (USD Million)
Table 6 Global Respiratory Disease Vaccine Market Size, By Streptococcus Pneumoniae, By Geography, 2017-2025 (USD Million)
Table 7 Global Respiratory Disease Vaccine Market Size, By Tuberculosis, By Geography, 2017-2025 (USD Million)
Table 8 Global Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 9 Global Respiratory Disease Vaccine Market Size, By Bacterial Vaccine, By Geography, 2017-2025 (USD Million)
Table 10 Global Respiratory Disease Vaccine Market Size, By Combination Vaccine, By Geography, 2017-2025 (USD Million)
Table 11 Global Respiratory Disease Vaccine Market Size, By Viral Vaccine, By Geography, 2017-2025 (USD Million)
Table 12 Global Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 13 Global Respiratory Disease Vaccine Market Size, By Adolescent Vaccination, By Geography, 2017-2025 (USD Million)
Table 14 Global Respiratory Disease Vaccine Market Size, By Adult Vaccination, By Geography, 2017-2025 (USD Million)
Table 15 Global Respiratory Disease Vaccine Market Size, By Infant Vaccination, By Geography, 2017-2025 (USD Million)
Table 16 Americas Respiratory Disease Vaccine Market Size, By Geography, 2017-2025 (USD Million)
Table 17 Americas Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 18 Americas Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 19 Americas Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 20 Argentina Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 21 Argentina Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 22 Argentina Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 23 Brazil Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 24 Brazil Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 25 Brazil Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 26 Canada Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 27 Canada Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 28 Canada Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 29 Mexico Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 30 Mexico Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 31 Mexico Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 32 United States Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 33 United States Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 34 United States Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 35 Europe, Middle East & Africa Respiratory Disease Vaccine Market Size, By Geography, 2017-2025 (USD Million)
Table 36 Europe, Middle East & Africa Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 37 Europe, Middle East & Africa Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 38 Europe, Middle East & Africa Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 39 France Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 40 France Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 41 France Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 42 Germany Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 43 Germany Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 44 Germany Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 45 Italy Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 46 Italy Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 47 Italy Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 48 Netherlands Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 49 Netherlands Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 50 Netherlands Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 51 Qatar Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 52 Qatar Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 53 Qatar Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 54 Russia Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 55 Russia Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 56 Russia Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 57 Saudi Arabia Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 58 Saudi Arabia Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 59 Saudi Arabia Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 60 South Africa Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 61 South Africa Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 62 South Africa Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 63 Spain Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 64 Spain Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 65 Spain Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 66 United Arab Emirates Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 67 United Arab Emirates Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 68 United Arab Emirates Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 69 United Kingdom Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 70 United Kingdom Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 71 United Kingdom Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 72 Asia-Pacific Respiratory Disease Vaccine Market Size, By Geography, 2017-2025 (USD Million)
Table 73 Asia-Pacific Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 74 Asia-Pacific Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 75 Asia-Pacific Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 76 Australia Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 77 Australia Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 78 Australia Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 79 China Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 80 China Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 81 China Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 82 India Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 83 India Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 84 India Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 85 Indonesia Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 86 Indonesia Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 87 Indonesia Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 88 Japan Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 89 Japan Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 90 Japan Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 91 Malaysia Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 92 Malaysia Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 93 Malaysia Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 94 Philippines Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 95 Philippines Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 96 Philippines Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 97 South Korea Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 98 South Korea Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 99 South Korea Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 100 Thailand Respiratory Disease Vaccine Market Size, By Infection, 2017-2025 (USD Million)
Table 101 Thailand Respiratory Disease Vaccine Market Size, By Type, 2017-2025 (USD Million)
Table 102 Thailand Respiratory Disease Vaccine Market Size, By Age Group, 2017-2025 (USD Million)
Table 103 Global Respiratory Disease Vaccine Market: Scores
Table 104 Global Respiratory Disease Vaccine Market: Business Strategy
Table 105 Global Respiratory Disease Vaccine Market: Product Satisfaction
Table 106 Global Respiratory Disease Vaccine Market: Ranking
Table 107 Global Respiratory Disease Vaccine Market: Merger & Acquisition
Table 108 Global Respiratory Disease Vaccine Market: Agreement, Collaboration, & Partnership
Table 109 Global Respiratory Disease Vaccine Market: New Product Launch & Enhancement
Table 110 Global Respiratory Disease Vaccine Market: Investment & Funding
Table 111 Global Respiratory Disease Vaccine Market: Award, Recognition, & Expansion
List of Figures
Figure 1. Global Respiratory Disease Vaccine Market: Research Process
Figure 2. Global Respiratory Disease Vaccine Market: Research Execution
Figure 3. Global Respiratory Disease Vaccine Market Size, 2019 Vs 2025 (USD Million)
Figure 4. Global Respiratory Disease Vaccine Market Size, By Infection, 2019 Vs 2025 (USD Million)
Figure 5. Global Respiratory Disease Vaccine Market Size, By Type, 2019 Vs 2025 (USD Million)
Figure 6. Global Respiratory Disease Vaccine Market Size, By Age Group, 2019 Vs 2025 (USD Million)
Figure 7. Global Respiratory Disease Vaccine Market Size, By Geography, 2019 Vs 2025 (USD Million)
Figure 8. Competitive Analysis In Global Respiratory Disease Vaccine Market, By Type
Figure 9. Global Respiratory Disease Vaccine Market: Market Dynamics
Figure 10. Global Respiratory Disease Vaccine Market: Porters Five Forces Analysis
Figure 11. Americas Respiratory Disease Vaccine Market Size, By Geography, 2019 Vs 2025 (USD Million)
Figure 12. Europe, Middle East & Africa Respiratory Disease Vaccine Market Size, By Geography, 2019 Vs 2025 (USD Million)
Figure 13. Asia-Pacific Respiratory Disease Vaccine Market Size, By Geography, 2019 Vs 2025 (USD Million)
- AstraZeneca
- Bavarian Nordic
- Bayer AG
- Bio Farma
- Dynavax Technologies Corporation
- Emergent BioSolutions, Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Seqirus USA Inc.
LOADING...
